Is ruxolitinib/ruxolitinib cream worth buying? Where can I buy it?
Ruxolitinib/ruxolitinib cream (ruxolitinib) has high clinical value in the treatment of atopic dermatitis (AD) and vitiligo due to its unique mechanism of action and good efficacy. This drug may be a better option for patients who suffer from chronic itching, recurring dermatitis, or white spots. However, because its price is relatively high and it has not yet been officially launched in mainland China, patients need to weigh the economic cost and treatment needs before deciding whether to purchase it.
At present, ruxolitinib cream has been approved for marketing in the United States, Europe, Japan and other places, and has been included in the medical insurance systems of some countries. In mainland China, the drug is still in the approval stage and has not yet entered the market. Therefore, if domestic patients need to purchase ruxolitinib cream, they usually need to purchase it through overseas channels, such as cross-border e-commerce, purchasing agents, or going to overseas pharmacies.
Purchase channels and price analysis
1. Original drug price: The specification of ruxolitinib cream marketed abroad is usually 1.5%*60g. The price in the United States and Europe is higher, with the price per box being around RMB 20,000. Final price may vary due to exchange rate fluctuations and import costs.
2. Price of generic drugs: Countries such as Bangladesh have produced generic versions of ruxolitinib cream, with specifications of 1.5%*30g, and the price per box is between RMB 600-1,000. Although the active ingredients of generic drugs are the same as the original drugs, the quality and efficacy may vary due to different production processes. Therefore, it is recommended to obtain them through formal channels to ensure drug quality.
Is it worth buying?
If the patient's condition is mild and can be controlled by traditional topical medications (such as tacrolimus ointment, glucocorticoids), there may be no need to choose the expensive ruxolitinib cream. However, for patients whose disease is more severe, has recurring attacks, or who do not respond significantly to traditional treatments, the drug may be an option worth trying. Especially in the treatment of vitiligo, ruxolitinib cream may provide new hope for patients.
Reference: https://www.opzelura.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)